Saving lives through technology

We want our AI technology to
not only perform in the highest level,
but also to serve for ‘the right’ purposes.
For us, this is ‘saving more lives.’

We aim to solve the most critical issues
in cancer care today:
reduce medical cost and prolong survival.

As a company, our philosophy is
to follow value over profit.
Our eyes are fixed in the fundamental
and inherent values,
while we simply take a portion
of the fruit we bear.

  • Our Vision
  • Team Lunit
  • Our Journey
Online Demo

Our Vision

Perfecting Intelligence,
Transforming Medicine.

Lunit, a portmanteau of ‘Learning unit,’ is a medical AI software company
devoted to providing AI-powered total cancer care.
Our AI solutions help discover cancer and predict cancer treatment outcomes,
achieving timely and individually-tailored cancer treatment.

Lunit Core Values

*Lunit AI researchers,
Seonwook Park and Thijs Kooi.

  • Be Original

    We are not afraid to step apart from
    the crowd and become different.
    We value originality and try hard to uphold it.

  • Motivate Yourself

    The strongest drive for achievement
    comes from within oneself.
    We are passionate and self-driven.

  • Live to Learn

    Growth excites us. It is in our DNA.
    We are people who enjoy learning and
    there is nothing we can’t learn.

  • Build with Evidence

    Ideas can come from intuitions,
    but the journey in making ideas into
    reality is built with robust evidence.

  • Push for Craftsmanship

    We pursue craftsmanship to achieve
    perfection and maintain high credibility.
    We create an impact and make changes.

  • Love One Another

    We value and appreciate the people
    we work with, and this is how we put ourselves
    in others' shoes and think for
    ways to help them.

Leadership Principles

  • Lead by Example
    Leaders at Lunit do not sit high above and direct with words. They are people who rise to their feet and get their hands dirty. That does not mean they should “do it all”. They are constantly in action, motivating others to act with them.
  • Be the Intelligent Processor
    The work process requires a leader’s intelligent intervention. Some of these include swift problem solving, constant clarification, and fast decision making that can make things running smoothly.
  • You Raise Me Up
    A leader at Lunit cares, supports, acknowledges, and inspires people by being thoughtful and considerate. They are committed to empowering team members, providing opportunities for them to rise to the occasion and make impactful achievements.
  • Listen, Think, Communicate and Over-Communicate
    Communication is key to cooperative work. Leaders must first listen, thoroughly think, analyze, and go to great lengths to communicate and over-communicate, making sure the team is on the same page.
  • Heart of a World Champion
    A champion pushes for excellence. A champion rises to the top. A champion is bold and courageous. Leading with the heart of a world champion means all of the above, added with a global mindset. As a company that provides medical solutions, we believe our solutions are inherently universal, impacting all human beings around the globe. Leaders at Lunit never cease to keep that perspective.
  • Always a Step Ahead.
    Your Vision Is Our Vision
    A leader always looks ahead and looks forward, guiding the path and the direction we are heading onto. Seek for what’s next and what is to come.

Team Lunit

We’re Lunit
“Learning Unit”

Beomseok Brandon Suh

Chief Executive Officer

Hyeonseong Park

Chief Financial Officer

Donggeun Yoo

Co-founder, Chief of Research

Anthony Paek

Co-founder, Executive Chairman, Chief Innovation Officer

Sunggyun Park

Co-founder, Chief Product Officer, Cancer Screening Group

Kihwan Kim

Chief Medical Officer, Cancer Screening Group

Minhong Jang

Co-founder, Chief Business Officer, Cancer Screening Group

Kyunghyun Paeng

Co-founder, Chief Product Officer, Cancer Screening Group

Chan-Young Ock

Chief Medical Officer, Oncology Group

Ken Nesmith

Chief Business Officer, Business Development Division, Oncology Group

Jungin Lee

Co-founder, VP of Regulation

Marcus Róin Skovhus

VP of Corporate Development

Jussarang Lee

VP of Branding and Communications, Corporate Affairs Division, Common Group

Gajin Kim

VP of Employee Experience Dept., Corporate Affairs Division, Common Group

Jane Rah

VP of Finance & Accounting,Corporate Affairs Division, Common Group

Eunsu Jamie Park

VP of Product, Innovation Division, Common Group

Terri Kim

VP of Strategy, Innovation Division, Common Group

Thijs Kooi

VP of Research, Product Division, Cancer Screening Group

Soochul Bang

VP of Software Development, Product Division, Cancer Screening Group

Yoonjin Kim

VP of Regulation Dept., Product Division, Cancer Screening Group

Jaehoon Ahn

VP of Solution Engineering, Product Division, Cancer Screening Group

JaeMin Oh

VP of Global Sales, Business Development Division, Cancer Screening Group

Chanick Park

VP of Korea Sales & Sales Acceleration, Business Development Division, Cancer Screening Group

Sergio Pereira

VP of Research, Product Division, Oncology Group

Jeongseok Kang

VP of Software Development, Product Division, Oncology Group

Paul Rohricht

VP of Business Development, Business Development Division, Oncology Group

Ryan Choi

VP of Clinical Research, Medical Affairs Division, Cancer Screening Group

Jimin Chang

Design Chapter Lead, Brand Experience Designer

Our Journey

A First Generation
Medical AI Start-up

History

2020

    • Recommended by the World Health Organization (WHO) as a diagnostic tool to replace medical professionals in tuberculosis screenings
    • Raised $26M (Series C, Tranche B)
    • Raised $61M (Pre-IPO)
    • PMDA approved <CXR-AID>, a collaboration between Fujifilm and Lunit, in Japan
    • FDA cleared <Lunit INSIGHT MMG>
    • FDA cleared <Lunit INSIGHT CXR Triage>
    • First showcase for <Lunit INSIGHT Chest CT>, <Lunit INSIGHT DBT>
    • ‘Digital Health 150’ by CB Insights
    • Raised $26M (Series C, Tranche A)
    • Europe CE certified, <Lunit INSIGHT MMG>
    • Awarded by World Economic Forum as one of 100 “Technology Pioneer 2020”
    • Digital Health 150, by CB Insights
    • Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT MMG>
    • Europe CE marked, <Lunit INSIGHT CXR>
    • 1st place in <Visual Domain Adaptation Challenge>
    • Raised $15M (Series B)
    • Ministry of Korea Food and Drug Safety clearance, <Lunit INSIGHT CXR-Nodule>
    • Launched its second product, <Lunit INSIGHT MMG>
    • Top 100 AI startup, by CB Insights
    • Top 5 “Social Impact” AI startup, by NVIDIA
    • Ranked 1st place in <CAMELYON Grand Challenge 2017>
    • 5th place in <The Digital Mammography DREAM Challenge 2017>
    • Launched its first product, <Lunit INSIGHT CXR-Nodule>
    • Raised $3.5M (Series A)
    • 1st place in MICCAI Tumor Proliferation Assessment Challenge 2016

Fundraising
History

Series

Closing Date

Investment

Lead Investor

Other Investor

SeriesSeed

Closing Date2014. 05

Investment$0.1M

Lead InvestorKakao Ventures

Other Investor-

SeriesSeries A

Closing Date2015. 10

Investment$2M

Lead InvestorSoftbank Ventures Asia(Korea/Japan)

Other InvestorKakao Ventures, Formation 8 (USA)

SeriesSeries A1

Closing Date2016. 09

Investment$3.3M

Lead InvestorSoftbank Ventures Asia

Other InvestorKakao Ventures, Mirae Asset Venture Investment, Intervest

SeriesSeries B

Closing Date2018. 06

Investment$15M

Lead InvestorIntervest

Other InvestorSoftbank Ventures Asia, Kakao Ventures, Mirae Asset Venture Investment, Intervest, KT Investment, Legend Capital (China)

SeriesSeries B1

Closing Date2019. 08

Investment$5M

Lead InvestorFujiFilm (Japan)

Other InvestorLegend Capital

SeriesSeries C (Tranche A)

Closing Date2019. 12

Investment$27M

Lead InvestorShinhan Investment

Other InvestorKakao Ventures, Intervest, IMM Investment, Legend Capital, LG CNS, NH Investment&Securities

SeriesSeries C (Tranche B)

Closing Date2021.07

Investment$26M

Lead InvestorGuardant Health (USA)

Other Investor-

SeriesPre-IPO (Tranche A)

Closing Date2021.11

Investment$22M

Lead InvestorNaver

Other InvestorKakao Ventures, Softbank Ventures Asia, IMM Investment, Mirae Asset Venture Investment, Naver Cloud

SeriesPre-IPO (Tranche B)

Closing Date2021.11

Investment$39M

Lead InvestorHealthQuest Capital (USA)

Other InvestorTybourne Capital (USA), Legend Capital, Casdin Capital (USA), BrightEdge (USA), NSG Ventures (SGP)

SeriesSeed

Closing Date2014. 05

Investment$0.1M

Lead InvestorKakao Ventures

Other Investor-

SeriesSeries A

Closing Date2015. 10

Investment$2M

Lead InvestorSoftbank Ventures Asia(Korea/Japan)

Other InvestorKakao Ventures, Formation 8 (USA)

SeriesSeries A1

Closing Date2016. 09

Investment$3.3M

Lead InvestorSoftbank Ventures Asia

Other InvestorKakao Ventures, Mirae Asset Venture Investment, Intervest

SeriesSeries B

Closing Date2018. 06

Investment$15M

Lead InvestorIntervest

Other InvestorSoftbank Ventures Asia, Kakao Ventures, Mirae Asset Venture Investment, Intervest, KT Investment, Legend Capital (China)

SeriesSeries B1

Closing Date2019. 08

Investment$5M

Lead InvestorFujiFilm (Japan)

Other InvestorLegend Capital

SeriesSeries C (Tranche A)

Closing Date2019. 12

Investment$27M

Lead InvestorShinhan Investment

Other InvestorKakao Ventures, Intervest, IMM Investment, Legend Capital, LG CNS, NH Investment&Securities

SeriesSeries C (Tranche B)

Closing Date2021.07

Investment$26M

Lead InvestorGuardant Health (USA)

Other Investor-

SeriesPre-IPO (Tranche A)

Closing Date2021.11

Investment$22M

Lead InvestorNaver

Other InvestorKakao Ventures, Softbank Ventures Asia, IMM Investment, Mirae Asset Venture Investment, Naver Cloud

SeriesPre-IPO (Tranche B)

Closing Date2021.11

Investment$39M

Lead InvestorHealthQuest Capital (USA)

Other InvestorTybourne Capital (USA), Legend Capital, Casdin Capital (USA), BrightEdge (USA), NSG Ventures (SGP)

Our Investors

Watch and learn more about Lunit

Lunit YouTube

Products

AI for Radiology
and Oncology